Business Description
Nova Mentis Life Science Corp
NAICS : 541714
SIC : 3741
ISIN : CA53069P1018
Compare
Compare
Traded in other countries / regions
NOVA.CanadaNMLSF.USAHN3Q.Germany IPO Date
2013-05-06Description
Nova Mentis Life Science Corp is a Canadian-based biotechnology company. It is engaged in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. Nova uses psilocybin in the treatment of Fragile X Syndrome (FXS). The company's goal is to diagnose and treat debilitating chronic conditions that have unmet medical needs such as autism spectrum disorder (ASD) and FXS. It has one industry segment, being research and development of psilocybin, and in one geographic area, which is Canada.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -11.13 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -1676.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 28.3 | |||||
| 3-Year EPS without NRI Growth Rate | 27.7 | |||||
| 3-Year FCF Growth Rate | 25.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.74 | |||||
| 9-Day RSI | 53.64 | |||||
| 14-Day RSI | 51.38 | |||||
| 6-1 Month Momentum % | -39.56 | |||||
| 12-1 Month Momentum % | -67.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.06 | |||||
| Quick Ratio | 0.06 | |||||
| Cash Ratio | 0.04 | |||||
| Days Sales Outstanding | 117.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -65.3 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -4075 | |||||
| Net Margin % | -6360.71 | |||||
| FCF Margin % | -3771.43 | |||||
| ROE % | -2729.5 | |||||
| ROA % | -409.43 | |||||
| ROIC % | -637.43 | |||||
| ROC (Joel Greenblatt) % | -8298.18 | |||||
| ROCE % | -1741.98 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.9 | |||||
| EV-to-EBITDA | -1.91 | |||||
| EV-to-Revenue | 75.76 | |||||
| EV-to-FCF | -2.09 | |||||
| Earnings Yield (Greenblatt) % | -52.63 | |||||
| FCF Yield % | -46.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NMLSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nova Mentis Life Science Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.021 | ||
| EPS (TTM) ($) | -0.011 | ||
| Beta | 0 | ||
| Volatility % | 76.23 | ||
| 14-Day RSI | 51.38 | ||
| 14-Day ATR ($) | 0.001861 | ||
| 20-Day SMA ($) | 0.010478 | ||
| 12-1 Month Momentum % | -67.29 | ||
| 52-Week Range ($) | 0.0069 - 0.053 | ||
| Shares Outstanding (Mil) | 147.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nova Mentis Life Science Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nova Mentis Life Science Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nova Mentis Life Science Corp Frequently Asked Questions
What is Nova Mentis Life Science Corp(NMLSF)'s stock price today?
The current price of NMLSF is $0.01. The 52 week high of NMLSF is $0.05 and 52 week low is $0.01.
When is next earnings date of Nova Mentis Life Science Corp(NMLSF)?
The next earnings date of Nova Mentis Life Science Corp(NMLSF) is .
Does Nova Mentis Life Science Corp(NMLSF) pay dividends? If so, how much?
Nova Mentis Life Science Corp(NMLSF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers